Drug-carrying DNA aptamers can deliver a one-two punch to leukemia by precisely targeting the elusive cancer stem cells that seed cancer relapses, researchers report. The aptamers -- short ...

Diagnosed with chronic T-cell LGL at 31, the author faced initial disbelief from doctors and a challenging prognosis. Despite numerous treatments, the focus shifted from survival to quality of life, ...

Large Granular Lymphocyte Leukemia (LGLL) is a rare, chronic lymphoproliferative disorder primarily defined by the clonal expansion of cytotoxic T cells or natural killer (NK) cells. Clinically, the ...

In a new study published in Nature Communications, a research team at the University of Oslo have examined how cancer cells ...

CD123, a leukemia cell-surface marker present in more than 80% of cases, is involved in cancer cell growth and survival and is especially elevated in high-risk subtypes. "We wanted a study that could ...